Gro Østli Eilertsen

478 total citations
22 papers, 367 citations indexed

About

Gro Østli Eilertsen is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Gro Østli Eilertsen has authored 22 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 15 papers in Immunology and 4 papers in Oncology. Recurrent topics in Gro Østli Eilertsen's work include Systemic Lupus Erythematosus Research (18 papers), T-cell and B-cell Immunology (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Gro Østli Eilertsen is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), T-cell and B-cell Immunology (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Gro Østli Eilertsen collaborates with scholars based in Norway, Australia and United States. Gro Østli Eilertsen's co-authors include Johannes C. Nossent, Andrea Becker-Merok, Warren Raymond, Marijke Van Ghelue, Gunnstein Bakland, Premasany Kanapathippillai, Kristin Andreassen Fenton, Ole Petter Rekvig, Tove Aminda Hanssen and Silje Fismen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Gro Østli Eilertsen

22 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gro Østli Eilertsen Norway 11 247 243 68 62 44 22 367
M. A. Petri United States 7 266 1.1× 328 1.3× 95 1.4× 35 0.6× 57 1.3× 10 403
Panagiotis Garantziotis Greece 11 217 0.9× 237 1.0× 67 1.0× 48 0.8× 34 0.8× 26 402
S N Wong China 8 191 0.8× 218 0.9× 53 0.8× 32 0.5× 31 0.7× 10 303
Michel Tsang-A-Sjoe Netherlands 10 214 0.9× 311 1.3× 160 2.4× 46 0.7× 53 1.2× 22 436
Cary M. Looney Switzerland 6 169 0.7× 182 0.7× 81 1.2× 50 0.8× 38 0.9× 9 314
Yunyun Fei China 9 148 0.6× 203 0.8× 30 0.4× 44 0.7× 71 1.6× 14 368
Vasileios Vazgiourakis Greece 10 252 1.0× 200 0.8× 52 0.8× 57 0.9× 90 2.0× 25 431
Punchong Hanvivadhanakul Thailand 7 305 1.2× 359 1.5× 79 1.2× 98 1.6× 58 1.3× 11 481
Andrea Becker-Merok Norway 7 172 0.7× 239 1.0× 41 0.6× 34 0.5× 37 0.8× 8 332
Reinmar Undeutsch Germany 7 322 1.3× 234 1.0× 31 0.5× 39 0.6× 64 1.5× 12 507

Countries citing papers authored by Gro Østli Eilertsen

Since Specialization
Citations

This map shows the geographic impact of Gro Østli Eilertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gro Østli Eilertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gro Østli Eilertsen more than expected).

Fields of papers citing papers by Gro Østli Eilertsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gro Østli Eilertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gro Østli Eilertsen. The network helps show where Gro Østli Eilertsen may publish in the future.

Co-authorship network of co-authors of Gro Østli Eilertsen

This figure shows the co-authorship network connecting the top 25 collaborators of Gro Østli Eilertsen. A scholar is included among the top collaborators of Gro Østli Eilertsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gro Østli Eilertsen. Gro Østli Eilertsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Thao H., Morten Wang Fagerland, Tom Eirik Mollnes, et al.. (2022). Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis. PLoS ONE. 17(2). e0264628–e0264628. 8 indexed citations
2.
Raymond, Warren, et al.. (2021). Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus. Lupus Science & Medicine. 8(1). e000537–e000537. 15 indexed citations
3.
Nguyen, Thao H., Morten Wang Fagerland, Gunnbjørg Hjeltnes, et al.. (2021). Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. PLoS ONE. 16(6). e0253793–e0253793. 3 indexed citations
4.
Eilertsen, Gro Østli, et al.. (2020). En mann i 60-årene med akutte ryggsmerter og økende kraftsvikt i underekstremitetene. Tidsskrift for Den norske legeforening. 140(5). 1 indexed citations
5.
6.
Raymond, Warren, et al.. (2019). The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus. Journal of Clinical Medicine. 8(6). 857–857. 8 indexed citations
7.
Raymond, Warren, Gro Østli Eilertsen, & Johannes C. Nossent. (2018). Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus. Cytokine. 114. 67–73. 17 indexed citations
8.
Kanapathippillai, Premasany, et al.. (2018). Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. Scientific Reports. 8(1). 7861–7861. 35 indexed citations
9.
Raymond, Warren, et al.. (2018). FRI0350 Lupus low disease activity state (LLDAS-50) is a significant predictor for damage accrual and mortality: a norwegian cohort analysis. Annals of the Rheumatic Diseases. 77. 711–711. 1 indexed citations
10.
Jones, Heather, Warren Raymond, Gro Østli Eilertsen, & Johannes C. Nossent. (2018). Soluble erythropoietin receptor levels associate with inflammatory mediators but not with disease activity or cumulative organ damage in patients with systemic lupus erythematosus. European Journal of Inflammation. 16. 1 indexed citations
11.
Raymond, Warren, Gro Østli Eilertsen, & Johannes C. Nossent. (2018). Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus. Journal of Immunology Research. 2018. 1–7. 9 indexed citations
12.
Worm, A M, et al.. (2017). Dermatological moulage collections in the Nordic countries. Journal of the European Academy of Dermatology and Venereology. 32(4). 570–580. 4 indexed citations
13.
Gullstrand, Birgitta, Søren Jacobsen, Gro Østli Eilertsen, et al.. (2016). The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study. Arthritis Research & Therapy. 18(1). 44–44. 5 indexed citations
14.
Nossent, Johannes C., Warren Raymond, & Gro Østli Eilertsen. (2016). Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. Lupus Science & Medicine. 3(1). e000162–e000162. 12 indexed citations
15.
Rekvig, Ole Petter, Anders Bengtsson, Gunnar Sturfelt, et al.. (2014). Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study. Lupus Science & Medicine. 1(1). e000007–e000007. 19 indexed citations
16.
Eilertsen, Gro Østli, Marijke Van Ghelue, & Johannes C. Nossent. (2012). BAFF Expression is Increased in Patients with Lupus Nephritis and Associated with Antinucleosome Antibodies, C1 Inhibitor, Α-1-Acid-Glycoprotein and Endothelial Activation Markers. Duo Research Archive (University of Oslo). 3(1). 1 indexed citations
17.
18.
Eilertsen, Gro Østli, Silje Fismen, Tove Aminda Hanssen, & Johannes C. Nossent. (2010). Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy. Nephrology Dialysis Transplantation. 26(2). 620–627. 13 indexed citations
19.
Becker-Merok, Andrea, Gro Østli Eilertsen, & Johannes C. Nossent. (2010). Levels of Transforming Growth Factor-β Are Low in Systemic Lupus Erythematosus Patients with Active Disease. The Journal of Rheumatology. 37(10). 2039–2045. 73 indexed citations
20.
Eilertsen, Gro Østli, Andrea Becker-Merok, & Johannes C. Nossent. (2009). The Influence of the 1997 Updated Classification Criteria for Systemic Lupus Erythematosus: Epidemiology, Disease Presentation, and Patient Management. The Journal of Rheumatology. 36(3). 552–559. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. A. Petri Breakdown of academic impact, for papers by Panagiotis Garantziotis Breakdown of academic impact, for papers by S N Wong Breakdown of academic impact, for papers by Michel Tsang-A-Sjoe Breakdown of academic impact, for papers by Cary M. Looney Breakdown of academic impact, for papers by Yunyun Fei Breakdown of academic impact, for papers by Vasileios Vazgiourakis Breakdown of academic impact, for papers by Punchong Hanvivadhanakul Breakdown of academic impact, for papers by Andrea Becker-Merok Breakdown of academic impact, for papers by Reinmar Undeutsch
Rankless by CCL
2026